Niels W C J van de Donk (N W C J van de Donk)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Clinical Evaluation

Acute Lymphoblastic Leukemia

Multiple Myeloma

Acinetobacter Baumannii

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Christie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans, Kristine A Frerichs, Wassilis S C Bruins, Carolien Duetz, Sandy Kruyswijk, S Rubina Baglio, Sheri Skerget, Rocio Montes de Oca, Sonja Zweegman, Raluca I Verona, Tuna Mutis, Niels W C J van de Donk
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Niels W C J van de Donk, Sonja Zweegman
BCMA-directed therapy for early relapsed and/or refractory multiple myeloma. Nature reviews. Clinical oncology (2024)
Crescenzo Massaro, Hilal N Sensoy, Manon Mulders, Celine De Schrijver, Cristina Gómez-Martin, Juan Simon-Nieto, Tonny Lagerweij, Alisha Atmopawiro, Jennifer Pérez-Boza, Maarten P Bebelman, Leontien Bosch, Simone Foderaro, Mafalda Neves Ferreira, Monique A J van Eijndhoven, Jan R T van Weering, Carmela Dell'Aversana, Lucia Altucci, C Dilara Savci-Heijnink, Niels W C J van de Donk, Cristina Giorgio, Laura Brandolini, Marcello Allegretti, Dirk Michiel Pegtel, S Rubina Baglio
Tumor-secreted extracellular vesicles counteract therapy response by triggering inflammatory mesenchymal stem cell development. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Christie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans, Kristine A Frerichs, Wassilis S C Bruins, Carolien Duetz, Sandy Kruyswijk, S Rubina Baglio, Sheri Skerget, Rocio Montes de Oca, Sonja Zweegman, Raluca I Verona, Tuna Mutis, Niels W C J van de Donk
T cell characteristics impact response and resistance to T cell-redirecting bispecific antibodies in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Niels W C J van de Donk, Clément Huysentruyt, Mario R P Dhooge
Loss of vision as the first manifestation of amyloid light-chain amyloidosis. EJHaem 5 (3) (2024)
Charlotte L B M Korst, Kazimierz Groen, Patricia W C Bosman, Fleur van der Valk, Christie P M Verkleij, Sandy Kruyswijk, Maaike E M de Ruijter, Dianne M Heijink, Maria T Kuipers, Sonja Zweegman, Niels W C J van de Donk
Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step-up dosing. HemaSphere 8 (7) (2024)
Jort J van der Schans, Ziyu Wang, Jennemiek van Arkel, Thijs A Van Schaik, Afroditi Katsarou, Ruud Ruiter, Thomas Baardemans, Huipin Yuan, Joost D de Bruijn, Sonja Zweegman, Niels W C J van de Donk, Richard W J Groen, Maria Themeli, Tuna Mutis
Specific targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptors T-cells directed against CD38 and CD138. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Charissa Wijnands, Somayya Noori, Niels W C J van de Donk, Martijn M vanDuijn, Joannes F M Jacobs
Advances in minimal residual disease monitoring in multiple myeloma. Critical reviews in clinical laboratory sciences (2023)
Chloe O'Neill, Niels W C J van de Donk
T-cell redirecting bispecific antibodies in multiple myeloma: Current landscape and future directions. EJHaem 4 (3) (2023)
Alexa M G A Laheij, Niels W C J van de Donk
Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Maarten R Seefat, David G J Cucchi, K Groen, M L Donker, K G van der Hem, M Westerman, A M Gerrits, A Beeker, Niels W C J van de Donk, Hedwig M Blommestein, Sonja Zweegman
Treatment sequences and drug costs from diagnosis to death in multiple myeloma. European journal of haematology (2023)
Kristine A Frerichs, Monique C Minnema, Mark-David Levin, Annemiek Broijl, Gerard M J Bos, Marie José Kersten, Tuna Mutis, Christie P M Verkleij, Inger S Nijhof, Patricia W C Maas-Bosman, Saskia K Klein, Sonja Zweegman, Pieter Sonneveld, Niels W C J van de Donk
Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma. Blood advances 5 (23) (2022)
Niels W C J van de Donk
How We Manage Newly Diagnosed Multiple Myeloma With Circulating Tumor Cells. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Mashhour Hosny, Christie P M Verkleij, Jort van der Schans, Kristine A Frerichs, Tuna Mutis, Sonja Zweegman, Niels W C J van de Donk
Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma. Journal of clinical medicine 10 (19) (2021)
Renée Poels, Esther Drent, Roeland Lameris, Afroditi Katsarou, Maria Themeli, Hans J van der Vliet, Tanja D de Gruijl, Niels W C J van de Donk, Tuna Mutis
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma. International journal of molecular sciences 22 (3) (2021)
Jakub Radocha, Niels W C J van de Donk, Katja Weisel
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma. Cancers 13 (7) (2021)
Kristine A Frerichs, Christie P M Verkleij, Meletios- Athanasios Dimopoulos, Jhon A Marin Soto, Sonja Zweegman, Mary H Young, Kathryn J Newhall, Tuna Mutis, Niels W C J van de Donk
Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients. Cancers 13 (10) (2021)
Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik, Jorge Mansilla-Soto, Dionysia Kefala, Georgios Kladis, Alexandros Nianias, Ruud Ruiter, Renée Poels, Irene Sarkar, Yash R Patankar, Elena Merino, Rogier M Reijmers, Kristine A Frerichs, Huipin Yuan, Joost D de Bruijn, Dina Stroopinsky, David Avigan, Niels W C J van de Donk, Sonja Zweegman, Tuna Mutis, Michel Sadelain, Richard W J Groen, Maria Themeli
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence. Science translational medicine 13 (623) (2021)
Christie P M Verkleij, Amy Jhatakia, Marloes E C Broekmans, Kristine A Frerichs, Sonja Zweegman, Tuna Mutis, Natalie A Bezman, Niels W C J van de Donk
Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies. Cancers 12 (12) (2020)
Laurens E Franssen, Tuna Mutis, Henk M Lokhorst, Niels W C J van de Donk
Immunotherapy in myeloma: how far have we come? Therapeutic advances in hematology 10 (2019)
Niels W C J van de Donk, Tineke Casneuf, Alessandro Di Cara, Paul W Parren, Sonja Zweegman, Berris van Kessel, Henk M Lokhorst, Saad Z Usmani, Sagar Lonial, Paul Gerard Richardson, Christopher Chiu, Tuna Mutis, Inger S Nijhof, A Kate Sasser
Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma. British journal of haematology 184 (3) (2018)